These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17459901)

  • 1. Effect of nitric oxide synthase inhibition on haemodynamics and outcome of patients with persistent cardiogenic shock complicating acute myocardial infarction: a phase II dose-ranging study.
    Dzavík V; Cotter G; Reynolds HR; Alexander JH; Ramanathan K; Stebbins AL; Hathaway D; Farkouh ME; Ohman EM; Baran DA; Prondzinsky R; Panza JA; Cantor WJ; Vered Z; Buller CE; Kleiman NS; Webb JG; Holmes DR; Parrillo JE; Hazen SL; Gross SS; Harrington RA; Hochman JS;
    Eur Heart J; 2007 May; 28(9):1109-16. PubMed ID: 17459901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of tilarginine acetate in patients with acute myocardial infarction and cardiogenic shock: the TRIUMPH randomized controlled trial.
    ; Alexander JH; Reynolds HR; Stebbins AL; Dzavik V; Harrington RA; Van de Werf F; Hochman JS
    JAMA; 2007 Apr; 297(15):1657-66. PubMed ID: 17387132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracarotid infusion of the nitric oxide synthase inhibitor, L-NMMA, modestly decreases cerebral blood flow in human subjects.
    Joshi S; Young WL; Duong DH; Ostapkovich ND; Aagaard BD; Hashimoto T; Pile-Spellman J
    Anesthesiology; 2000 Sep; 93(3):699-707. PubMed ID: 10969303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose-response study of nitric oxide synthase inhibition in different vascular beds in man.
    Hjorth Lassen L; Klingenberg Iversen H; Olesen J
    Eur J Clin Pharmacol; 2003 Oct; 59(7):499-505. PubMed ID: 13680036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in renal and systemic hemodynamics after NO-synthase inhibition in males with family history of hypertension.
    Berger ED; Bader BD; Rüb N; Rauscher MA; Rebenschütz I; Gaber OC; Enderle MD; Risler T; Erley CM
    Kidney Blood Press Res; 2002; 25(1):42-9. PubMed ID: 11834876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expert opinion on tilarginine in the treatment of shock.
    Howes LG; Brillante DG
    Expert Opin Investig Drugs; 2008 Oct; 17(10):1573-80. PubMed ID: 18808317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue oxygenation and hemodynamic response to NO synthase inhibition in septic shock.
    Broccard A; Hurni JM; Eckert P; Liaudet L; Schaller MD; Lazor R; Perret C; Feihl F
    Shock; 2000 Jul; 14(1):35-40. PubMed ID: 10909891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo quantification of endotoxin-induced nitric oxide production in pigs from Na15NO3-infusion.
    Santak B; Radermacher P; Iber T; Adler J; Wachter U; Vassilev D; Georgieff M; Vogt J
    Br J Pharmacol; 1997 Dec; 122(8):1605-10. PubMed ID: 9422804
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrarenal haemodynamics and renal dysfunction in endotoxaemia: effects of nitric oxide synthase inhibition.
    Millar CG; Thiemermann C
    Br J Pharmacol; 1997 Aug; 121(8):1824-30. PubMed ID: 9283724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a nitric oxide synthase inhibitor on pressor response to angiotensin II in conscious rats.
    Maeda T; Yoshimura T; Ohshige A; Koyama H; Ito M; Okamura H
    Artery; 1998; 23(1):1-9. PubMed ID: 10846613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of nitric oxide synthase inhibition on systemic, hepatic, and renal hemodynamics in patients with cirrhosis and ascites.
    Spahr L; Martin PY; Giostra E; Niederberger M; Lang U; Capponi A; Hadengue A
    J Investig Med; 2002 Mar; 50(2):116-24. PubMed ID: 11928940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamic effects of inhibition of nitric oxide synthase and of L-arginine at rest and during exercise.
    Brett SE; Cockcroft JR; Mant TG; Ritter JM; Chowienczyk PJ
    J Hypertens; 1998 Apr; 16(4):429-35. PubMed ID: 9797188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide synthase inhibition restores orthostatic tolerance in young vasovagal syncope patients.
    Stewart JM; Sutton R; Kothari ML; Goetz AM; Visintainer P; Medow MS
    Heart; 2017 Nov; 103(21):1711-1718. PubMed ID: 28501796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. L-NMMA (a nitric oxide synthase inhibitor) is effective in the treatment of cardiogenic shock.
    Cotter G; Kaluski E; Blatt A; Milovanov O; Moshkovitz Y; Zaidenstein R; Salah A; Alon D; Michovitz Y; Metzger M; Vered Z; Golik A
    Circulation; 2000 Mar; 101(12):1358-61. PubMed ID: 10736276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ocular hemodynamic response to nitric oxide synthase inhibition is unaltered in patients with early type I diabetes.
    Dorner GT; Garhöfer G; Selenko N; Fasching P; Bayerle-Eder M; Schmetterer L; Wolzt M
    Graefes Arch Clin Exp Ophthalmol; 2003 Aug; 241(8):619-24. PubMed ID: 12836035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of inotropic and chronotropic effects of NG-monomethyl-L-arginine.
    Brillante DG; O'Sullivan AJ; Johnstone MT; Howes LG
    Eur J Clin Invest; 2009 Apr; 39(4):273-9. PubMed ID: 19292882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men.
    Muskiet MH; Tonneijck L; Smits MM; Kramer MH; Diamant M; Joles JA; van Raalte DH
    Diabetes Obes Metab; 2016 Feb; 18(2):178-85. PubMed ID: 26636423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action.
    Shankar R; Zhu JS; Ladd B; Henry D; Shen HQ; Baron AD
    J Clin Invest; 1998 Oct; 102(7):1403-12. PubMed ID: 9769333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of nos inhibition on retinal arterial and capillary circulation in early arterial hypertension.
    Michelson G; Wärntges S; Harazny J; Oehmer S; Delles C; Schmieder RE
    Retina; 2006 Apr; 26(4):437-44. PubMed ID: 16603964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF.
    Tilton RG; Chang KC; LeJeune WS; Stephan CC; Brock TA; Williamson JR
    Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):689-96. PubMed ID: 10067972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.